ADVFN US – Market Content Editor
-

Kraig Biocraft Laboratories Highlights Spider Silk Fashion Opportunity as Production Advances
Kraig Biocraft Laboratories is positioning its recombinant spider silk for potential fashion and textile applications after reporting production of approximately 3.2 metric tons of cocoons in a single production cycle earlier this year. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Biocraft Laboratories is using New York Fashion Week to highlight the potential…
-

IonQ Presents Nine Peer-Reviewed Quantum Computing Papers at IEEE Quantum Week 2026
IonQ is presenting nine peer-reviewed papers at IEEE Quantum Week 2026, including four Best Paper Award recipients, with research spanning quantum machine learning, industrial simulation, protein folding, logistics and quantum error reduction. Key Investor Takeaways Why IONQ Stock Is in Focus IonQ’s nine peer-reviewed papers at IEEE Quantum Week put the emphasis on measurable application-level…
-

Linkage Global Signs Non-Binding LOI for Up to $20 Million PIPE Investment
Linkage Global signed a non-binding letter of intent with Capital Finance Limited for a potential two-tranche PIPE investment of up to $20 million, with the larger second tranche tied to a planned search for an AI hardware manufacturing acquisition target. Key Investor Takeaways Why UZX Stock Is in Focus Linkage Global’s proposed PIPE investment establishes…
-

Cellectis Announces In Vivo Gene Editing Transformation, Exits Lasme-cel and Eti-cel Development
Cellectis is shifting its development strategy toward in vivo gene editing after reporting preclinical proof-of-concept for .HEAL-101 and .HEAL-201, while ending development of two allogeneic CAR-T programs and realigning operations to extend its cash runway into the second half of 2028. Key Investor Takeaways Why CLLS Stock Is in Focus Cellectis’ in vivo gene editing…
-

3 E Network Deploys CFD Simulation and Digital Twin Technologies at Mikkeli AI Data Center
3 E Network is integrating CFD simulation and Digital Twin technologies into its Mikkeli AI data center in Finland, extending the project from physical infrastructure design toward software-based thermal, cooling and operational management for future high-density AI computing. Key Investor Takeaways Why MASK Stock Is in Focus 3 E Network is moving forward with the…
-

RF Industries Reports Record Q3 Fiscal 2026 Sales as Profitability Expands
RF Industries posted record third-quarter fiscal 2026 net sales of nearly $24 million, alongside higher margins, net income and adjusted EBITDA as bookings supported a $19.8 million current backlog. Key Investor Takeaways Why RFIL Stock Is in Focus RF Industries’ record Q3 fiscal 2026 sales were accompanied by improvement across several profitability measures, providing investors…
-

Hain Celestial Reports FY2026 Results as North America Margins Improve
Hain Celestial reported lower fiscal 2026 sales and adjusted EBITDA, while fourth-quarter North America organic growth, margin expansion and stronger free cash flow highlighted progress ahead of the planned sale of its International business. Key Investor Takeaways Why HAIN Stock Is in Focus Hain Celestial’s fiscal 2026 results showed a business that became smaller following…
-

Why a Major Gold Producer Invested $5.4M Before Phenom’s First Drill Hole
In exploration, a promising gold target is one thing. Having a major gold producer invest before you’ve even drilled the first hole is quite another. Hello, I’m Ricki Lee, and this is The Capital Compass. Today we’re looking at Phenom Resources (USOTC:PHNMF) (TSXV:PHNM), a Nevada-focused explorer with exposure to both gold and vanadium — but…
-

BioNTech Shares Rise 6.4% After Updated Gotistobart Lung Cancer Trial Data
BioNTech SE (NASDAQ:BNTX) shares rose 6.4% in pre-market trading on Monday after the company reported updated survival data from stage 1 of the Phase 3 PRESERVE-003 trial evaluating gotistobart in patients with squamous non-small cell lung cancer. Gotistobart produced median overall survival of 18.5 months, compared with 10.0 months for standard-of-care docetaxel chemotherapy in patients…
-

Oracle Begins New Round of Job Cuts as AI Infrastructure Spending Rises – Report
Oracle Corp (NYSE:ORCL) has begun another round of job cuts, Business Insider reported on Monday, citing three affected employees and an email obtained by the publication. The layoffs began on Monday, in line with expectations from a source familiar with the matter, according to the report. An Oracle spokesperson had not responded to a request…